tiprankstipranks
Trending News
More News >
Acelyrin says Concentra indication not expected to result in superior proposal
PremiumThe FlyAcelyrin says Concentra indication not expected to result in superior proposal
2M ago
Acelyrin, Alumis reaffirm strategic, financial rationale of proposed merger
Premium
The Fly
Acelyrin, Alumis reaffirm strategic, financial rationale of proposed merger
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Alumis, Acelyrin to merge in all-stock transaction
PremiumThe FlyAlumis, Acelyrin to merge in all-stock transaction
3M ago
Acelyrin Inc trading halted, news pending
Premium
The Fly
Acelyrin Inc trading halted, news pending
3M ago
ACELYRIN, INC. Ends Key Agreement with Affibody
Premium
Company Announcements
ACELYRIN, INC. Ends Key Agreement with Affibody
3M ago
Acelyrin announces additional lonigutamab data, design for LONGITUDE program
PremiumThe FlyAcelyrin announces additional lonigutamab data, design for LONGITUDE program
4M ago
Acelyrin price target lowered to $5 from $6 at Morgan Stanley
Premium
The Fly
Acelyrin price target lowered to $5 from $6 at Morgan Stanley
5M ago
Acelyrin price target lowered to $13 from $15 at Wells Fargo
Premium
The Fly
Acelyrin price target lowered to $13 from $15 at Wells Fargo
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100